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Abstract
Toxic effects of chloramphenicol, an antibiotic inhibitor of mitochondrial protein synthesis, on rat liver derived RL-34 cell
line were completely blocked by a combined treatment with substances endowed with direct or indirect antioxidant
properties. A stable, nitroxide free radical scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, and a protein synthesis
inhibitor, cycloheximide, suppressed in a similar manner the following manifestations of the chloramphenicol cytotoxicity :
(1) Oxidative stress state as evidenced by FACS analysis of cells loaded with carboxy-dichlorodihydrofluorescein diacetate
and Mito Tracker CMTH2MRos; (2) megamitochondria formation detected by staining of mitochondria with MitoTracker
CMXRos under a laser confocal microscopy and electron microscopy; (3) apoptotic changes of the cell detected by the phase
contrast microscopy, DNA laddering analysis and cell cycle analysis. Since increases of ROS generation in chloramphenicol-
treated cells were the first sign of the chloramphenicol toxicity, we assume that oxidative stress state is a mediator of above
described alternations of RL-34 cells including MG formation. Pretreatment of cells with cycloheximide or 4-hydroxy-
2,2,6,6-tetramethylpiperidine-1-oxyl, which is known to be localized into mitochondria, inhibited the megamitochondria
formation and succeeding apoptotic changes of the cell. Protective effects of cycloheximide, which enhances the expression of
Bcl-2 protein, may further confirm our hypothesis that the megamitochondria formation is a cellular response to an increased
ROS generation and raise a possibility that antiapoptotic action of the drug is exerted via the protection of the mitochondria
functions. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis (programmed cell death, PCD) is con-
trolled by an intrinsic genetic program remarkably
conserved in evolution, playing an essential role in
proper development and maintenance of the func-
tional properties of tissues and organs [1,2]. Apopto-
sis is induced by a variety of factors like tropic fac-
tors deprivation [3], heat shock [4], and many
cytotoxic substances [5,6]. Reports have been accu-
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mulated connecting early steps of the activation of
the apoptosis with the breakdown of the mitochon-
drial functions [7,8]. Many factors responsible for the
activation of active cell death, like cytochrome c [9]
and proapoptotic members of bax protein family, or
conversely those responsible for the inhibition of this
process like antiapoptotic members of bcl-2 family,
are located in mitochondria [10^12].
An important factor implicated in the di¡erent
steps of apoptosis is an enhanced generation of re-
active oxygen species (ROS) [13]. Oxidative stress
state is a common element of PCD induced by var-
ious stimuli which often do not exert a direct oxidant
action [6,14,15]. Moreover, substances with antioxi-
dative properties are reported to inhibit apoptosis
induced by various unrelated inducers [16^19]. Slater
et al. [17] reported protective e¡ect of nitroxide,
2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) on
thymocyte apoptosis induced by etoposide or gluco-
corticoid methylprednisolone. Nitroxides, stable and
cell permeable radicals, protect cellular macromole-
cules from oxidative damage by multiple mechanisms
including the scavenging of superoxide anions [20],
stimulation of catalase-like activity of hemoproteins
[21], stimulation of H2O2 decomposition by perox-
ides [22], or by mimicking SOD activity [23]. Sub-
stantial amount of 4-hydroxy-TEMPO (4-OH-TEM-
PO) is localized into mitochondria and microsomes
[24], where are the places with high rates of oxygen
metabolism and possible sources of ROS related to
oxidative stress [25]. Cycloheximide (CHX), a potent
inhibitor of apoptosis, protects neurons by a mecha-
nism involving the induction of antioxidant enzymes,
and antiapoptotic bcl-2 protein [26] which also works
at the level of the inhibition of oxidative stress by
suppressing ROS generation [27] or decreasing lipid
peroxidation which is a manifestation of ROS toxic-
ity [28]. Other possible mechanism of antiapoptotic
activity of CHX was reported by Ratan et al. [29]. By
shunting cysteine from protein synthesis to gluta-
thione CHX enhanced cellular antioxidant defense
and protected embryonic cortical neurons from
apoptotic changes of the cell induced by oxidative
stress [29].
Chloramphenicol (CP) is an antibiotic inhibitor of
the mitochondrial protein synthesis. Data have been
accumulated concerning the CP toxicity for eucary-
otic cells [30] connecting it with the inhibition of
mitochondrial protein synthesis and DNA damage
[31], and a direct interaction of its p-nitro group
with cellular macromolecules [32] including reduced
glutathione [33]. Major manifestation of CP intoxi-
cation may be explained by the attack of free radicals
[30]. Morphological manifestation of the CP treat-
ment is the formation of gigantic mitochondria
(magamitochondria, MG) [34,35]. Although the CP-
induced formation of MG is widely accepted as a
result of the inhibition of protein synthesis in mito-
chondria [34] we have demonstrated previously that
4-OH-TEMPO suppresses the MG formation and at
the same time oxidative stress state induced by CP,
suggesting that free radicals may be intimately re-
lated to the mechanism of the CP-induced formation
of MG [36]. Recently, we have demonstrated that the
formation of MG is often followed by apoptotic
changes of the cell in di¡erent cell lines [37].
To evaluate the ‘mitochondrial stress’ involvement
in the apoptotic changes of the cell we investigated
the e¡ect of CP on the fate of the liver derived RL-34
cells. We demonstrate evidence that antiapoptotic
e¡ects of antioxidant 4-OH-TEMPO and those of
CHX are closely related to the prevention of ROS
generation and mitochondrial alternations.
2. Materials and methods
2.1. Cell culture
Rat liver derived cell line RL-34 [38] (JCRBO247)
were maintained in DMEM (‘Nissui 2’) supple-
mented with 10% heat-inactivated fetal calf serum
(FCS), 4 mM L-glutamine, 0.45% glucose and 60
mg/l kanamycin and were grown on 10-cm tissue
culture dishes (Falcon) at 37‡C in a humidi¢ed 5%
CO2 atmosphere.
2.2. Treatment of RL-34 cells with chemicals
The following chemicals were tested in the present
study: CP (100^500 Wg/ml), CHX (0.5 Wg/ml) and 4-
OH-TEMPO (1^2 mM). CHX or 4-OH-TEMPO was
added to the culture medium 1 h before the addition
of CP.
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2.3. Determination of the growth rate of the cells
RL-34 cells were cultured on 96-well dishes in the
presence or absence of the drugs, speci¢ed above.
Growth rates of cells cultured in various experimen-
tal conditions were assayed using Cell Counting Kit-
8 (Dojindo Laboratories, Tokyo, Japan) based on
the conversion of colorless WST-8 (2(-methoxy-4-ni-
trophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfenyl)-2H-te-
trazolium, monosodium salt) into WST-8 formazan.
All manipulations were performed according to the
manufacturer’s instructions.
2.4. DNA fragmentation assay
Nuclear DNA was extracted from cultured cells by
the method of Garland and Halestrap [39]. Cells cul-
tured on 60-mm tissue culture dishes for various
lengths of time in the presence or absence of various
chemicals were washed twice with cold PBS and
lysed with 500 Wl of a bu¡er containing 10 mM
Tris^HCl (pH 8.0), 0.1 mM EDTA, 150 mM KCl
and 1% sodium dodecyl sulfate (SDS) for 5 min on
ice, incubated for 1 h at 37‡C with DNase-free
RNase (10 U/ml) (Sigma Chemical Co., St. Louis,
MO). Proteinase K (200 Wg/ml) (Sigma) was then
added to the incubation mixture and samples were
incubated overnight at 37‡C. DNA was extracted
with phenol/chloroform/isoamyl alcohol (25:24:1,
v/v/v), precipitated by the addition of 3.5 M ammo-
nium acetate and 2.5 volumes of ice-cold absolute
ethanol at 380‡C for 2 h, and resuspended in TE
bu¡er (10 mM Tris^HCl (pH 7.4), 1 mM EDTA).
Extracted DNA (10 Wg/lane) was subjected to the
1.8% agarose electrophoresis and visualized by ethi-
dium bromide staining.
2.5. Cell cycle analysis
Cell cycle analysis was performed by £ow cytome-
try, using nuclei essentially according to the method
of Mancini et al. [40] as described before [37]. DNA
staining was obtained with 500 Wl of a solution con-
taining 100 Wg/ml of propidium iodide (Molecular
Probes, Eugene, OR), 0.1% Triton X-100 and 1% fetal
calf serum for 30 min at 4‡C in the dark, followed by
£ow cytometric analysis using a Coulter Epics XL
£ow cytometer (Coulter Corp., Miami, FR).
2.6. Evaluation of the rate of ROS generation
Overall intracellular ROS generation was meas-
ured following the formation of carboxy-dichloro-
£uorescein (carboxy-DCF), a £uorescent derivative
of carboxy-dichlorodihydro£uorescein diacetate (car-
boxy-H2-DCFDA) (Molecular Probes) [28,40].
Brie£y, cells were loaded with 5 WM carboxy-H2-
DCFDA and incubated for 60 min at 37‡C in a
humidi¢ed 5% CO2 atmosphere. After incubation,
cells were washed with PBS (pH 7.4), resuspended
in PBS and submitted immediately to analysis using
a Coulter Elite FACSCAN (Coulter) with excitation
and emission settings of 495 and 525 nm, respec-
tively. Counting of cells was stopped at 10 000.
Gating were performed prior to the collection of
data to remove apoptotic cells and cellular debris.
The extramitochondrial oxidative stress has been
measured using a non£uorescent dye, Mito Tracker
CMTH2MRos (Molecular Probes). The dye can be
selectively sequestered by mitochondria only after it
is oxidized in the cytoplasm to a £uorescent dye
CMTMRos [41]. The reduced form of the dye
CMTH2MRos cannot be oxidized by mitochondria,
thus the £uorescent intensity of CMTMRos obtained
after staining cells with CMTHM2Ros represents the
total amount of ROS generated inside the cell ex-
cluding the amount of ROS generated from mito-
chondria.
ROS generation from isolated rat liver mitochon-
dria were analyzed by £ow cytometry according to
Garcia-Ruiz et al. [42]. Brie£y, mitochondria isolated
by di¡erential centrifugation, from 6-week-old male
Wistar rats according to the method described before
[43], were incubated at 1 mg protein/ml for 1 h at
25‡C in the presence of 5 WM carboxy-H2-DCFDA.
Oxidizable substrates used were: 5 mM succinate
and 5 mM glutamate (+5 mM malate). Inhibitors
used were: 20 WM rotenone, 0.5 mM antimycin A,
and 2.5 mM KCN. They were added to the reaction
mixture immediately after the addition of the dye.
FACS analysis was performed as described above
on whole cells.
2.7. Cell staining with mitochondria-speci¢c
£uorescent probes
Analysis of the morphology of mitochondria with
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£uorescent probes was performed according to Poot
et al. [44]. Cells growing on the coverglasses (10U10
mm) in 12-well tissue culture dishes were stained with
500 nM mitochondrial speci¢c £uorescent dye Mito
Tracker Red CMXRos (Molecular Probes). Cells
were incubated with the dye for 30 min at 37‡C in
the culture medium, rinsed with performed PBS, and
¢xed for 30 min at room temperature by a ¢xative
containing 2% formaldehyde and 2% glutaraldehyde
in PBS. After washing with PBS cells were air-dried,
mounted with Perma Fluor solution and observed
under the Bio-Rad Lasersharp MRC 1024 scanning
confocal microscopy system. Staining speci¢city of
the dye was con¢rmed with other mitochondria-spe-
ci¢c dyes MitoTracker Green FM and Mito Tracker
CMTMRos.
2.8. Measurements of the membrane potential of
mitochondria
For £ow cytometric analyses of mitochondrial
membrane potential (vim) cells growing on the 10-
cm dishes were incubated with 500 nM CMTMRos
for 30 min at 37‡C. After washing with prewarmed
PBS cells were collected by trypsinization and sub-
mitted to the FACS analysis according to the meth-
od of Poot et al. [44]. In some experiments the mem-
brane potential of mitochondria was measured in the
presence of 50 Wg/ml gramicidin.
2.9. Western blot analysis
For Western blot analysis, solubilized proteins
were separated by SDS^polyacrylamide gel electro-
phoresis (15% gel), transferred to Immobilon-P
PVDF membrane (Millipore Corp., Bedford, MA).
After the overnight blocking step with 3% BSA,
0.02% sodium vanadate in PBS samples were immu-
nostained with anti-Bcl-2 monoclonal antibody
(1:250) (Transaction Laboratories, Lexington, KY)
in the presence of blocking solution. Immunoreactive
proteins were incubated with alkaline phosphatase-
conjugated secondary antibodies, and signals were
detected with a BCIP/NBT detection system.
2.10. Electron microscopy
Detached and adherent cells growing on the 10-cm
culture dishes were ¢xed in situ by the direct addition
of an equal volume of 8% glutaraldehyde in 0.2 M
cacodylate bu¡er (pH 7.4) to the dish. After ¢xation
for 1 h at 4‡C, attached cells were scraped o¡ and the
whole suspension was centrifuged at 10 000Ug for
5 min, washed in 0.1 M cacodylate bu¡er (pH 7.4),
post-¢xed with 1% osmium tetroxide for 1 h, dehy-
drated with a graded series of ethanol and embedded
in Epon. Thin sections were stained with lead citrate
and examined in a Hitachi H-7000 electron micro-
scope operated at 75 kV.
3. Results
3.1. E¡ects of CHX and 4-OH-TEMPO on the rate
of the generation of ROS from CP-treated
RL-34 cells
Fig. 1 details the e¡ects of a spin trap 4-OH-TEM-
PO and a cytoplasmic protein synthesis inhibitor
CHX on the rate of the ROS generation from CP-
treated cells. In Fig. 1A, the averaged £uorescence
intensity of carboxy-DCF per cell in each experimen-
tal group was plotted against the time after the ad-
dition of CP to the culture medium. Changes in the
oxidation of carboxy-H2-DCFDA into its £uorescent
derivative carboxy-DCF re£ect the overall intracellu-
lar ROS generation including the ROS generation
from mitochondria. There was a burst in the ROS
generation in the cells treated with CP for 10 h and
the level of ROS of these cells reached the maximum
after 22 h, and then declined gradually. On the other
hand, the level of ROS in CP-treated cells in the
presence of the pretreatment with CHX (designated
as ‘(CP+CHX)-treated cells’, thereafter) remained as
low as that of the control cell. Suppressing e¡ects of
the pretreatment of cells with 4-OH-TEMPO on CP-
induced increases in the intracellular level of ROS
were less remarkable compared to those of CHX,
described above. Histograms of carboxy-DCF £uo-
rescence and CMTMRos £uorescence of RL-34 cells
treated with various experimental conditions are
shown in Fig. 1B and C, respectively. In Fig. 1B, a
distinct shift of the peak to the right was detected in
the cells treated with CP alone while the peak of
(CP+CHX)-treated cells remained essentially in the
same position as that of the control cells. On the
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other hand, a shift of the peak to the right was de-
tected in CP-treated cells in the presence of the pre-
treatment with 4-OH-TEMPO (designated as
‘(CP+4-OH-TEMPO)-treated cells’, thereafter)
although it was smaller than that of the CP-treated
cells. In Fig. 1C, CMTH2MRos has been adopted to
detect the extramitochondrial generation of ROS
since the dye cannot react with mitochondria unless
it is oxidized to a £uorescent dye CMTMRos. There
was a distinct shift of the peak to the right in CP-
treated cells as in the case of carboxy-DCF. When
cells were pretreated with CHX, such CP-induced
shift of the peak to the right was completely sup-
pressed, and even a shift of the peak to the left
was observed indicating that CHX suppressed the
extramitochondrial generation of ROS more e¡ec-
tively than the mitochondrial generation of ROS.
3.2. E¡ects of CHX and 4-OH-TEMPO on the
growth rate of CP-treated RL-34 cells
Fig. 2 demonstrates the growth rate of RL-34 cells
cultured in the presence of CP. It is obvious from the
¢gure that the growth rate of the cell was distinctly
suppressed by CP. When CP was removed from the
medium at 22 h, the growth rate of the cells recov-
ered distinctly.
Fig. 1. Flow cytometric analysis of intracellular levels of reac-
tive oxygen species (ROS) in CP-treated RL-34 cells. (A) Cells
were cultured for various lengths of time in the presence of CP
(300 Wg/ml), CP with the pretreatment with cycloheximide
(CHX) (abbreviated as ‘CP+CHX’ thereafter) (0.5 Wg/ml), or
with 4-OH-TEMPO (abbreviated as ‘CP+4-OH-TEMPO’ there-
after) (1 mM). ROS generations in the control and experimental
groups are expressed as the mean density of carboxy-DCF per
cell. (B) Typical histograms demonstrating overall intracellular
generations of ROS in CP-treated RL-34 cells using carboxy-
DCF, an oxidized form of carboxy-H2-DCFDA, per cell repre-
sents the intracellular level of ROS. Cells were cultured for 22
h under various experimental conditions described in A. (C)
Typical histograms demonstrating extramitochondrial genera-
tions of ROS in CP-treated RL-34 cells using CMTH2MRos.
The £uorescence intensity of CMTMRos, an oxidized form of
CMTH2MRos, per cell represents the amount of extramito-
chondrial generation of ROS. Cells were cultured for 22 h
under various experimental conditions described in A.
6
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3.3. E¡ects of CHX and 4-OH-TEMPO on
CP-induced apoptotic changes of RL-34 cells
Phase contrast micrographs of RL-34 cells cul-
tured for 48 h under various experimental conditions
are shown in Fig. 3. (CP+CHX)-treated (Fig. 3C) or
(CP+4-OH-TEMPO)-treated (Fig. 3D) cells as well
as the control cells (Fig. 3A) ¢rmly attached to the
dish forming a sheet whereas those treated with CP
alone (Fig. 3B) were smaller in their sizes and often
became round. Moreover, some of them were de-
tached from the dish displaying morphological char-
acteristics of apoptosis.
CP-induced apoptotic changes of the cells were
detected also by the electrophoretic analysis of nu-
clear DNA (Fig. 4A). Nuclear DNA extracted from
the cells treated with CP for 48 h showed a typical
ladder formation (lane 2), a biochemical marker of
apoptosis. On the other hand, the pretreatment of
the cells with CHX (lane 3) or 4-OH-TEMPO (lane
4) suppressed such CP-induced changes.
Cell cycle analysis of CP-treated RL-34 cells using
the propidium iodide staining method also detected
apoptotic changes of the cell : a small peak of a sub-
G1 population, which is indicative of the apoptotic
manner of the cell death, appeared in the cells cul-
tured for 22 h in the presence of CP. However, the
Fig. 3. Phase contrast micrographs of RL-34 cells cultured for 48 h in the absence (A) or presence of CP (B), CP+CHX (C) or
CP+4-OH-TEMPO (D). Detailed experimental conditions are described in Fig. 1A.
Fig. 2. Growth rate of RL-34 cells cultured for various lengths
of time in the presence of CP (300 Wg/ml). In some experiments,
cells were cultured for 22 h in the presence of CP when MG
were formed and then cells were cultured in the absence of CP.
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peak was as small as that of the control (data are not
shown). When the treatment of those cells with CP
was prolonged up to 48 h, the population of sub-G1
cells became distinctly larger than that of the control
and it reached to about 44% of the whole population
of the CP-treated cells after 72 h (Fig. 4B). On the
other hand, the population of sub-G1 cells remained
much smaller in (CP+CHX) or (CP+4-OH-TEM-
PO)-treated cells although it was statistically larger
than that of the control.
3.4. E¡ects of CHX and 4-OH-TEMPO on
CP-induced changes in the mitochondrial
membrane potential (vim) and those in the
volume of mitochondria
It has turned out that a large population of RL-34
cells become apoptotic when they are exposed to CP
Fig. 5. Changes in the membrane potential and the volume of
mitochondria in CP-treated RL-34 cells. Cells were cultured for
48 h in various experimental conditions described in Fig. 1A,
and then treated with gramicidin (50 Wg/ml). Cells were stained
with Mito Tracker CMTMRos and analyzed by £ow cytometry.
Details in the experimental conditions are described in Fig. 1A.
Fig. 4. Suppression of CP-induced apoptosis by CHX and 4-
OH-TEMPO. (A) Electrophoresis of nuclear DNA extracted
from RL-34 cells cultured for 48 h in the absence (lane 1) or
presence of CP (lane 2), CP+CHX (lane 3), or CP+4-OH-TEM-
PO (lane 4). Lane 5, size markers. Detailed experimental condi-
tions are described in Fig. 1A. (B) Population of apoptotic cells
in CP-treated RL-34 cells. Cells were cultured for 48 h and 72
h under various experimental conditions described in Fig. 1A.
Numbers of apoptotic cells in the control and experimental
groups were obtained by £ow cytometric analysis of propidium
iodide-stained cells. Presence of sub-G1 cell population was
used as an indicator of apoptosis. Data are the averages and
standard error (mean þ S.E.) of three di¡erent experiments.
Values of experimental groups are statistically di¡erent from
those of the control group at: a (0.0016P6 0.01),
b (0.016P6 0.02), c (0.026P6 0.05).
BBAMCR 14431 1-2-99
M. Karbowski et al. / Biochimica et Biophysica Acta 1449 (1999) 25^40 31
for longer periods of time such as 48 h to 72 h, as
shown in the previous section. Thus, a £ow cytomet-
ric analysis on CP-treated cells has been carried out
to detect the changes in the membrane potential of
mitochondria since decreases in the membrane po-
tential of mitochondria are intimately related to
apoptotic processes of the cell [8,45]. Cells were
stained with a potential dependent, mitochondria-
speci¢c £uorescent dye CMTMRos (Fig. 5). It was
unexpected to ¢nd a remarkable shift of the peak to
the right in the cells treated with CP for 48 h since
we expected decreases in the membrane potential of
mitochondria in these cells. At the same time, anoth-
er small peak with extremely low £uorescent inten-
sities was detected indicating a certain population of
the CP-treated cells became apoptotic with a col-
lapsed membrane potential of mitochondria. Pre-
treatment of the cells with CHX or 4-OH-TEMPO
improved these CP-induced changes and the peak
with low £uorescence intensities, described above,
was far less distinct compare to that observed in
CP-treated cells. There were two possible causes con-
Fig. 6. Confocal laser micrographs of RL-34 cells stained with CMXRos. Cells were cultured in the absence (A) or presence of CP
(B,C), CP+CHX (D), CP+4-OH-TEMPO (E), or CHX (F). Incubation time: A, C, D, E, F: 22 h; B: 15 h. Concentrations of chemi-
cals used were the same as those described in Fig. 1A.
C
Fig. 7. Electron micrographs of RL-34 cells cultured for 22 h in the absence (top left), or presence of CP (top right), CP+CHX (bot-
tom left), or CP+4-OH-TEMPO (bottom right). Concentrations of chemicals used were the same as those described in Fig. 1A.
U10 000.
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cerning the remarkable shift of the peak to the right
detected in the CP-treated cells: actual increases in
the membrane potential of mitochondria, or ap-
parent increases in the membrane potential of mito-
chondria due to increases in the total volume of mi-
tochondria per cell [45]. Thus, the following
experiments were carried out to distinguish the
changes in the membrane potential of mitochondria
from those in the total volume of mitochondria per
cell. For this purpose, the cells cultured for 48 h in
various experimental conditions were treated with 50
Wg/ml gramicidin, and stained with CMTMRos.
When numbers of cells of the control and experimen-
tal groups were plotted against the £uorescence in-
tensity of CMTMRos per cell remarkable shifts of
the peaks to the left were detected in all cases as
shown in Fig. 5, indicating that a CMTMRos uptake
by the cell was largely dependent on the H-ion gra-
dient. In the presence of gramicidin, cells in various
experimental conditions still maintained a basal mi-
tochondrial membrane potential that was independ-
ent of the proton gradient. However, the residual
CMTMRos uptake in the presence of gramicidin
was larger in experimental groups especially in the
CP-treated cells than in the control cells. These H-
ion independent increases in £uorescence in experi-
mental groups suggested a possibility that they might
re£ect the mitochondrial enlargement. Thus, mor-
phological changes of mitochondria in experimental
groups of cells were studied as described in the next
section. The di¡erence in the mean £uorescence in-
tensity with and without gramicidin of the control
cells was 101.4 arbitrary £uorescence units whereas
that of CP-treated cells was 54.1. This may indicate
that H-dependent membrane potential of CP-
treated cells was de¢nitely decreased compared to
that of the control cells. Corresponding values of
(CP+CHX)- and (CP+4-OH-TEMPO)-treated cells
were 82.1 and 81.1 arbitrary £uorescent units, respec-
tively, suggesting that the pretreatment of cells with
CHX or 4-OH-TEMPO improved to certain extent
CP-induced decreases in H-dependent membrane
potential of mitochondria.
3.5. E¡ects of CHX and 4-OH-TEMPO on
CP-induced morphological changes of
mitochondria
One of the most distinct structural changes ob-
served in RL-34 cells in early stages of the CP treat-
ment was the formation of MG (Fig. 6). Mitochon-
dria in the control cells stained with a £uorescent dye
CMXRos showed thin, ¢lamentous structures (Fig.
6A) under a confocal laser microscope, similar to
those in other cell lines reported by others [44,46].
Mitochondria in the cells treated with CP for 15 h
showed a mixed population of granular structures
and ¢lamentous ones (Fig. 6B), and the prolongation
of the incubation time of these cells with CP for up
Fig. 9. E¡ects of electron transfer chain inhibitors on the rate
of the generation of ROS from rat liver mitochondria. Rat liver
mitochondria were treated with antimycin A or KCN, in the
presence of succinate or glutamate as oxidizable substrate and
then stained with carboxy-H2-DCFDA.
Fig. 8. E¡ects of CHX and 4-OH-TEMPO on the level of bcl-2
protein in RL-34 cells cultured for 22 h in the presence of CP.
Control : lane 2; Control+CHX: lane 3; CP: lane 4;
CP+CHX: lane 5; Control+4-OH-TEMPO: lane 6; CP+4-OH-
TEMPO: lane 7. Size markers: lane 1. Concentrations of chem-
icals used were the same as those described in Fig. 1A.
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to 22 h revealed mitochondria predominantly in en-
larged and granular structures (Fig. 6C) indicating
the formation of MG. On the other hand, pretreat-
ment with CHX (Fig. 6D) or 4-OH-TEMPO (Fig.
6E) prevented CP-induced structural changes of mi-
tochondria, described above, and mitochondria re-
mained essentially in the same ¢lamentous structures
as those of the control cells. Mitochondria in cells
treated with CHX alone showed ¢lamentous struc-
tures but they were much slenderer than those in the
control cells (Fig. 6F). Staining cells with another
mitochondria-speci¢c £uorescent dye, Mito Tracker
Green FM showed similar results to those described
above (data are not shown). Structural changes of
mitochondria in the CP-treated cells are discerned
more clearly under the electron microscope (Fig. 7).
Mitochondria in RL-34 cells treated with CP for 22 h
became distinctly enlarged to various degrees with
extremely pale matrix (Fig. 7B) compared to those
of the control cells (Fig. 7A). Pretreatment of cells
with CHX (Fig. 7C) or 4-OH-TEMPO (Fig. 7D)
completely suppressed the CP-induced formation of
MG and succeeding apoptosis.
3.6. E¡ects of CHX on the level of bcl-2 protein in
CP-treated RL-34 cells
In the present study we have shown the suppress-
ing e¡ects of CHX and 4-OH-TEMPO on CP-in-
duced enhanced ROS generation and succeeding
MG formation and apoptotic changes of the cell.
Thus, we have examined the e¡ects of CHX and 4-
OH-TEMPO on the level of bcl-2 protein in the CP-
treated cells (Fig. 8) since changes in the rate of the
generation of ROS by various stimuli have been re-
ported to be intimately related to the changes in the
expression of anti-apoptotic bcl-2 protein [27,28].
There was not a noticeable di¡erence in the level of
bcl-2 protein between the control cells (Fig. 8, lane 2)
and those treated with CP alone (Fig. 8, lane 4)
whereas the pretreatment of cells with CHX induced
remarkable increases in both control (Fig. 8, lane 3)
and CP-treated cells (Fig. 8, lane 5). The pretreat-
ment of cells with 4-OH-TEMPO had no detectable
e¡ects on the expression of bcl-2 protein both in
control (Fig. 8, lane 6) and CP-treated cells (Fig. 8,
lane 7).
Fig. 10. Changes in the level of ROS in CP-treated RL-34 cells.
A. Cells were cultured for 22 h and 48 h in the presence and
absence of CP (300 Wg/ml). The overall intracellular level of
ROS was measured using carboxy-H2-DCFDA. B. Cells were
cultured for 22 h and 48 h in the presence and absence of CP
(300 Wg/ml). The extramitochondrial generation of ROS was
measured using CMTH2MRos. C and D. Mitochondria were
isolated from RL-34 cells cultured for 22 h and 48 h in the
presence and absence of CP (300 Wg/ml). The rate of the gener-
ation of ROS from mitochondria was measured using carboxy-
H2-DCFDA. Oxidizable substrates used were succinate for Fig
9C and glutamate (+ malate) for Fig. 9D.
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4. Discussion
We have shown in the present study that CHX and
4-OH-TEMPO, substances with antioxidative prop-
erties protected cells from apoptosis induced by ‘mi-
tochondrial stress’. Both drugs were e¡ective in sup-
pressing the CP-induced mitochondrial alterations
and ROS generation.
4.1. ROS generation from CP-induced MG
Increases in the ROS generation followed by apop-
totic changes of nuclei are the constant ¢ndings in
various experimental models of PCD: dexametha-
sone-induced thymocyte death [8] ; herbimycin-
treated colon adenocarcinoma [40]; lymphocytes in
acute HIV syndrome [47]. CP-induced formation of
MG in RL-34 cells shown in the present study was
preceded by distinct elevations of the intracellular
levels of ROS suggesting a possibility that free rad-
icals may be the main mediator of the formation of
MG. This is supported further by the fact that 4-OH-
TEMPO, a scavenger for free radicals, has sup-
pressed the CP-induced formation of MG as shown
in the present study. Previously, we have shown that
MG formations in primary cultured rat hepatocytes
treated with various chemicals including H2O2 are
invariably associated with an enhanced lipid peroxi-
dation. [48]. Furthermore, we have also previously
shown using rats or mice that antioxidants including
K-tocopherol, coenzyme Q10, besides 4-OH-TEMPO,
are capable of suppressing the formation of MG in-
duced by ethanol, hydrazine or CP [36,48^52]. Mito-
chondria are the main intracellular source of ROS
[53]. Alteration or disturbances in mitochondrial
electron transfer chains by free radicals or other toxic
stimuli may cause further elevations of the ROS pro-
duction by mitochondria leading to oxidative stress
state [54]. CP, a potent inhibitor of mitochondrial
protein synthesis, may cause an imbalance in electron
transfer chains and accelerate the production of
ROS. CP partly a¡ects the formation of respiratory
complex III which includes cytochrome b and com-
pletely inhibits the synthesis of cytochrome a+a3,
which is a component of complex IV, in various
organisms (for review, see Luzikov [55]). It has
been already reported that the contents of cyto-
chromes b and a+a3 of mitochondria in the liver of
mice treated with CP decrease to 25% and 80% of the
control, respectively [35].
It is known that superoxide is generated by com-
plexes I, II and III [56^58]. Oxygen superoxide is not
generated from complex IV containing cytochrome
a+a3 and the complex serves via its SOD activity
[59]. Furthermore, cytochrome oxidase, a major
component of complex IV has a very high a⁄nity
to oxygen so that the respiratory chain can work
optimally at very low oxygen tensions [60]. Since
the rate of the formation of superoxide increases lin-
early with the oxygen concentration, cytochrome
oxidase serves to lower the generation of superoxide.
Thus, decreases in the content of cytochromes b and
a+a3 of mitochondria in the liver of CP-treated ani-
mals, described above, may enhance the generation
of superoxide. In Fig. 9, the rate of the generation of
ROS from mitochondria was measured in the pres-
ence and absence of antimycin, an inhibitor of com-
plex III containing cytochrome b, and KCN, an in-
hibitor of complex IV containing cytochrome a+a3
to mimic expected changes in the content of cyto-
chromes in mitochondria of CP-treated cells. The
rate of the generation of ROS from mitochondria
when it was measured using succinate as the oxidiz-
able substrate in the presence of antimycin was es-
sentially the same as that measured in the absence of
antimycin, while it became slightly decreased when
glutamate (+malate) was used as the substrate. Data
shown above were in agreement with those shown by
Tan et al. recently [61]. They have shown that anti-
mycin A lowers the production of H2O2 in mito-
chondria isolated from HT 22 cells. On the other
hand, Chandel et al. [62] and Pitkanen et al. [63],
using mitochondria isolated from Hep3B cells and
rat heart mitochondria, respectively, showed in-
creases in the rate of the generation of ROS when
it was measured in the presence of antimycin A. If
the rate of the generation of ROS from complex III
is simply dependent upon the presence of compounds
that prolong the lifetime of ubisemiquinone which
reacts with molecular oxygen to generate ROS
[64,65], the presence of antimycin A should increase
the rate of generation of ROS. We have no exact
explanations to the controversial data, described
above, at the present time. When the rate of the
generation of ROS was measured in the presence of
KCN using succinate or glutamate (+malate) as oxi-
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dizable substrate de¢nitely became increased com-
pared to that measured in the absence of the inhib-
itor of the complex IV. We could deduce from the
date obtained with KCN that increases in the intra-
cellular level of ROS in CP-treated cells shown in the
present study (Fig. 1A) may be at least partly ex-
plained by increased ROS generation from mito-
chondria due to possible decreases in the levels of
cytochrome a+a3.
4.2. Mechanism of the CP-induced formation of MG
and succeeding apoptotic changes of the cell
In the present study we have shown that CP causes
distinct changes of the structure of mitochondria:
from ¢lamentous mitochondria to granular MG via
the folding of the former. We have previously shown
that remarkable changes in physicochemical and bio-
chemical properties of the mitochondrial membranes
take place which are favorable for the membrane
fusion during the formation processes of hydrazine-
and ethanol-induced formation of MG [50,52,66^68].
Based on these data, we have previously proposed
that MG are formed by the fusion of adjacent mito-
chondria. Since the intracellular levels of free radicals
are distinctly increased in the process of the CP-in-
duced formation of MG shown in the present study,
and the MG formation is suppressed by free radical
scavengers, ROS must be intimately related to the
mechanism of the formation of MG. However, a
serious question still remains unsolved even we ac-
cept that CP may induce MG by the fusion of ad-
jacent mitochondria: how free radicals modify the
mitochondrial membranes to form MG. Another
possibility for the mechanism of the CP-induced for-
mation of MG is by the suppression of the dividing
process of mitochondria due to decreased protein
synthesis [34,35]. A variety of data is available in
the literature concerning changes in the protein syn-
thesis in mitochondria caused by CP: decreases in
amino acid incorporation in mitochondria [69]; de-
creases in enzyme activities including cytochrome c
oxidase, oligomycin-sensitive ATPase, NADH dehy-
drogenase [70,71], decreases in the contents of cyto-
chromes b and a+a3 [35,70,71]. CP-induced MG in
RL-34 cells shown in the present study are charac-
terized by poorly developed cristae and extremely
pale matrix. Thus, the suppression of the protein
synthesis in mitochondria possibly contributed to
the formation of CP-induced MG. However, the cor-
relation between various data published in the liter-
ature concerning the inhibitory e¡ects of CP on pro-
tein synthesis and various enzyme activities in
mitochondria and the suppression of the dividing
processes of mitochondria is not clear at the present
time.
We have shown in the present study that the pro-
longation of the treatment of the cells with CP causes
apoptotic changes of the cell based on morphological
evidences and £ow cytometric analysis of the cell
using a £uorescent dye CMTMRos. Since the largest
population of the apoptotic cells examined in the
present study reached 48.9% of the total cells treated
with CP for 72 h (mean þ S.E.M.: 44.3 þ 2.1%), the
induction of the apoptotic cells by CP may not be
merely accidental. Then a question arises: what is the
correlation between the MG formation and the
apoptotic change of the cell? We speculate as follows
based on the data obtained in the present study and
those published in the literature. (1) When the cell is
exposed to various chemicals capable of generating
free radicals, intracellular levels of free radicals in-
crease. (2) MG are then formed by the fusion of
adjacent mitochondria and/or by the suppression of
the dividing processes of mitochondria. (3) Decreases
in the content of cytochrome a+a3 may accelerate the
generation of ROS from MG thus increasing intra-
cellular levels of ROS. Decreases in the content of
cytochrome a+a3 have been reported in hydrazine-
and ethanol-induced MG [72,73] besides CP-induced
MG [35]. (4) Further exposure of the cell to ROS
may result in the opening of the megachannels of
mitochondria and MG become swollen. (5) The swel-
ling of MG results in decreases in the membrane
potential of mitochondria leading to decreased rates
of oxygen consumption and decreased phosphorylat-
ing ability of MG. (6) Decreases in the metabolic
activity of the cell may result in decreases in the
overall intracellular levels of ROS. Decreases both
in extramitochondrial and mitochondrial generations
of ROS may contribute to relative decreases in over-
all intracellular levels of ROS (Fig. 10). Both extra-
mitochondrial and mitochondrial generation of ROS
detected by CMTH2MRos and carboxy-H2-DCFDA
were slightly larger in control cells cultured for 48 h
than those in control cells cultured 22 h, resulting in
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higher levels of intracellular ROS in the former than
those in the latter. On the contrary, extramitochon-
drial generations of ROS were de¢nitely smaller in
the cells treated with CP for 48 h than those in the
cells treated with CP 22 h. Mitochondrial generations
of ROS had a tendency to be smaller in the former
cells than those in the latter cells. Thus, overall intra-
cellular levels of ROS in the former cells were smaller
than those in the latter cells. (7) If decreases in the
rate of the generation of ROS from MG are e¡ective
enough to lower the overall intracellular levels of
ROS, or intracellular ROS are decreased to certain
levels by scavengers of free radicals, MG may return
to normal both structurally and functionally and re-
gain the ability to synthesize enough ATP to carry
out various cellular functions. If not, a series of
events connected with apoptotic processes of the
cell (releases of cytochrome c and of suicide proteins
from mitochondria to the cytoplasm, decreases in
intracellular levels of ATP, etc.) may take place
and the cell becomes apoptotic.
4.3. E¡ectiveness of CHX and 4-OH-TEMPO in
suppressing the CP-induced formation of MG and
succeeding apoptosis
We have shown in the present study that both
CHX and 4-OH-TEMPO cause remarkable reduc-
tions in the level of ROS in CP-treated cells. A com-
bined use of two ROS-sensitive probes carboxy-
H2DCFDA and CMTH2MRos may be an e⁄cient
tool for in vivo analysis of the mitochondrial and
extramitochondrial oxidative stress. Overall intracel-
lular levels of ROS can be detected by carboxy-
H2DCFDA whereas CMTH2MRos can react with
free radicals inside the cell but cannot enter mito-
chondria unless it is oxidized to form CMTMRos
[41]. Pretreatment of the cell with CHX or 4-OH-
TEMPO was e¡ective to suppress the CP-induced
oxidation of CMTH2MRos and carboxy-H2-
DCFDA, but the former was more e¡ective than
the latter although both suppressed the CP-induced
formation of MG and succeeding apoptotic changes
of the cell. The superiority of CHX to 4-OH-TEM-
PO with respect to their antioxidative activities
shown in the present study may be due to the acti-
vation of the ‘cell defence program’ by the former:
the activation of antioxidative enzymes including mi-
tochondrial superoxide dismutase and the induction
of the expression of early response genes including
Bcl-2 protein which work in the antioxidant pathway
[26]. It has already been shown that CHX protects
neurons against oxidative insults by a mechanism
involving induction of neuroprotective gene products
including the antiapoptotic gene bcl-2 and antioxi-
dant enzymes [28]. We have also shown in the
present study that the expression of Bcl-2 is en-
hanced in RL-34 cells treated with CHX. Other anti-
oxidative actions of CHX reported in the literature
include: the acceleration of glutathione synthesis by
shunting cysteine from the protein synthesis to glu-
tathione synthesis [29]; a metabolic arrest and low-
ering of the sensitivity of the cell to ATP depletion
which is a strong apoptotic signal [39]. CHX has
been reported recently to be e¡ective in inhibiting
glutamate-induced mitochondria ROS generation
and subsequent apoptosis in HT22 cells [61].
Disruption of mitochondrial functions, manifested
by the changes in H-gradient across the mitochon-
drial membranes, is an early sign of apoptotic cell
death. We have shown in the present study that the
prolongation of the incubation of the cells with CP
for up to 48 h causes increases in the volume of MG,
suggesting that MG become swollen and induces
apoptotic changes in a large population of the cells.
These changes were suppressed by CHX or 4-OH-
TEMPO.
We have successfully suppressed the CP-induced
MG formation and succeeding apoptotic changes of
the cell by CHX and 4-OH-TEMPO. However, sev-
eral serious questions remain to be solved: What is
the molecular mechanism by which MG are formed
by free radicals even if we accept that free radicals
are intimately related to the mechanism? Are there
gene(s) similar to or identical to mdm-10 [74] or
mdm-12 [75] which controls the size of mitochondria
and also the their distribution inside the yeast cells?
What are the roles of the cytoskeletal systems in the
maintenance of the mitochondrial structures?
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